A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies
暂无分享,去创建一个
Paolo Bonato | Jeffrey M. Hausdorff | Álvaro Sánchez-Ferro | Lynn Rochester | Jochen Klucken | Jeffrey M Hausdorff | Alberto J Espay | Aristide Merola | Serene S Paul | Fay B Horak | Joaquin A Vizcarra | Tiago A Mestre | Ralf Reilmann | Alice Nieuwboer | E Ray Dorsey | Bastiaan R Bloem | Walter Maetzler | F. Horak | R. Reilmann | B. Bloem | P. Bonato | E. Dorsey | A. Nieuwboer | L. Rochester | A. Espay | W. Maetzler | Á. Sánchez-Ferro | J. Klucken | A. Merola | T. Mestre | J. A. Vizcarra | S. Paul
[1] Holger Fröhlich,et al. From hype to reality: data science enabling personalized medicine , 2018, BMC Medicine.
[2] Kenneth D. Mandl,et al. A 21st-Century Health IT System - Creating a Real-World Information Economy. , 2017, The New England journal of medicine.
[3] A. Espay,et al. A Viewpoint on Wearable Technology-Enabled Measurement of Wellbeing and Health-Related Quality of Life in Parkinson’s Disease , 2016, Journal of Parkinson's disease.
[4] Günther Deuschl,et al. MDS research criteria for prodromal Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[5] Walter Maetzler,et al. Participatory design in Parkinson's research with focus on the symptomatic domains to be measured. , 2015, Journal of Parkinson's disease.
[6] Max A. Little,et al. Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease , 2017, PloS one.
[7] Suchi Saria,et al. Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score , 2018, JAMA neurology.
[8] Boo Johansson,et al. Self-reported activities of daily living and performance-based functional ability: a study of congruence among the oldest old , 2011, European journal of ageing.
[9] Anirvan Ghosh,et al. Evaluation of smartphone‐based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial , 2018, Movement disorders : official journal of the Movement Disorder Society.
[10] J. Eberling,et al. A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein , 2018, Journal of Parkinson's disease.
[11] A. Fasano,et al. Technology-based assessment of motor and nonmotor phenomena in Parkinson disease , 2018, Expert review of neurotherapeutics.
[12] Isaac S Kohane,et al. Time for a Patient-Driven Health Information Economy? , 2016, The New England journal of medicine.
[13] D. Heldman,et al. Clinician versus machine: reliability and responsiveness of motor endpoints in Parkinson's disease. , 2014, Parkinsonism & related disorders.
[14] Geraint Rees,et al. Clinically applicable deep learning for diagnosis and referral in retinal disease , 2018, Nature Medicine.
[15] Max A. Little,et al. Technology in Parkinson's disease: Challenges and opportunities , 2016, Movement disorders : official journal of the Movement Disorder Society.
[16] Ahmed Al-Jawad,et al. A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson’s disease , 2016, Journal of NeuroEngineering and Rehabilitation.
[17] Carlo Alberto Artusi,et al. Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases. , 2018, Parkinsonism & related disorders.
[18] Alan Godfrey,et al. Ambulatory activity in incident Parkinson’s: more than meets the eye? , 2013, Journal of Neurology.
[19] Jeffrey M. Hausdorff,et al. Gait alterations in healthy carriers of the LRRK2 G2019S mutation , 2011, Annals of neurology.